Lineage Cell Therapeutics
LCTX
#8747
Rank
C$0.35 B
Marketcap
C$1.42
Share price
-1.94%
Change (1 day)
-36.68%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -C$31.52 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$14.77 Million. In 2025 the company made an earning of -C$30.59 Million a decrease over its 2024 earnings that were of -C$30.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$31.52 Million3.06%
2025 -C$30.59 Million1.4%
2024 -C$30.16 Million-13.16%
2023 -C$34.73 Million9.83%
2022 -C$31.63 Million-54.24%
2021 -C$69.1 Million86.07%
2020 -C$37.14 Million-31.97%
2019 -C$54.59 Million-5.42%
2018 -C$57.72 Million1.1%
2017 -C$57.09 Million-31.06%
2016 -C$82.81 Million-10.38%
2015 -C$92.4 Million29.69%
2014 -C$71.25 Million31.68%
2013 -C$54.11 Million
2011 -C$26.26 Million89.78%
2010 -C$13.84 Million206.06%
2009 -C$4.53 Million-0.58%
2008 -C$4.55 Million164.89%
2007 -C$1.72 Million-30.22%
2006 -C$2.46 Million
2002 -C$2.86 Million-41.04%
2001 -C$4.85 Million-32.04%
2000 -C$7.13 Million-11.85%
1999 -C$8.09 Million
1997 -C$5.2 Million12.12%
1996 -C$4.64 Million106.25%
1995 -C$2.25 Million-11.11%
1994 -C$2.53 Million50%
1993 -C$1.69 Million20%
1992 -C$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.22 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA